Inventor
BUNNAGE MARK EDWARD
US36 patents
⚠️ This page may combine multiple inventors who share the name “BUNNAGE MARK EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
34 patentsUS6916927B2Jul 12, 2005
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction
PFIZER113 citations97
US9879022B2Jan 30, 2018
Bicyclic-fused heteroaryl or aryl compounds
PFIZER19 citations93
US9458168B2Oct 4, 2016
Bicyclic-fused heteroaryl or aryl compounds
PFIZER17 citations92
US6670366B1Dec 30, 2003
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
PFIZER36 citations92
US6458951B2Oct 1, 2002
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
PFIZER39 citations92
US6407114B1Jun 18, 2002
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction
PFIZER28 citations92
US6333330B1Dec 25, 2001
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction
PFIZER39 citations92
US6251904B1Jun 26, 2001
Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction
PFIZER35 citations92
US6677335B1Jan 13, 2004
Pharmaceutically active compounds
PFIZER28 citations90
US11702424B2Jul 18, 2023
Bicyclic-fused heteroaryl or aryl compounds
PFIZER4 citations85
US6723719B1Apr 20, 2004
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
PFIZER14 citations84
US10793579B2Oct 6, 2020
Bicyclic-fused heteroaryl or aryl compounds
PFIZER3 citations83
US10329302B2Jun 25, 2019
Bicyclic-fused heteroaryl or aryl compounds
PFIZER3 citations83
US6844362B2Jan 18, 2005
Indole derivatives useful for the treatment of diseases
PFIZER14 citations82
US7183294B2Feb 27, 2007
Indole derivatives useful for the treatment of diseases
PFIZER9 citations73
US7528170B2May 5, 2009
Sulfonamide derivatives for the treatment of diseases
PFIZER4 citations72
US7244766B2Jul 17, 2007
Sulfonamide derivatives for the treatment of diseases
PFIZER7 citations72
US7138527B2Nov 21, 2006
Indole derivatives useful for the treatment of diseases
PFIZER8 citations72
US6958402B2Oct 25, 2005
3-(imidazolyl)-2-alkoxypropanoic acids
PFIZER11 citations72
US6713496B2Mar 30, 2004
3-(imidazolyl)-2-alkoxypropanoic acids
PFIZER7 citations72
US7056934B2Jun 6, 2006
Nicotinamide derivatives useful as PDE4 inhibitors
PFIZER2 citations63
US12202836B2Jan 21, 2025
Bicyclic-fused heteroaryl or aryl compounds
PFIZER0 citations62
US7268147B2Sep 11, 2007
Compounds useful for the treatment of diseases
PFIZER3 citations62
US7241810B2Jul 10, 2007
Formamide derivatives for the treatment of diseases
PFIZER4 citations62
US6949577B2Sep 27, 2005
Pharmaceuticals
PFIZER6 citations62
US6919457B2Jul 19, 2005
3-(imidazolyl)-2-aminopropanoic acids
PFIZER2 citations62
US6759426B2Jul 6, 2004
3-(Imidazolyl)-2-aminopropanoic acids
PFIZER2 citations62
US7767715B2Aug 3, 2010
Sulfonamide derivatives for the treatment of diseases
PFIZER3 citations61
US7067660B2Jun 27, 2006
Process for the preparation of pyrazolopyrimidinones
PFIZER2 citations61
US7176311B2Feb 13, 2007
Process for preparing pharmaceutically active compounds
PFIZER2 citations60
US8013019B2Sep 6, 2011
Sulfonamide derivatives for the treatment of diseases
PFIZER0 citations51
US7547731B2Jun 16, 2009
Formamide derivatives for the treatment of diseases
PFIZER0 citations51
US6730786B2May 4, 2004
Process for the preparation of pyrazolopyrimidinones
PFIZER1 citations51
US7629358B2Dec 8, 2009
Compounds useful for the treatment of diseases
PFIZER0 citations41